
Novai is a UK Medtech company focused on combating blindness and disability through early detection and intervention for eye and brain diseases using DARC technology. Their innovative approach leverages advanced AI algorithms and patented biologics to identify disease activity at a cellular level, enhancing treatment selection and improving patient outcomes. With a strong emphasis on research and development, Novai has gained recognition in the Medtech space, winning multiple awards and accolades, including Best MedTech Startup 2023 and First Place at Tech Nation Rising Stars Grand Final 2024. The company is well-positioned in the healthcare market, aiming to transform clinical trials and patient care in ophthalmology and beyond.

Novai is a UK Medtech company focused on combating blindness and disability through early detection and intervention for eye and brain diseases using DARC technology. Their innovative approach leverages advanced AI algorithms and patented biologics to identify disease activity at a cellular level, enhancing treatment selection and improving patient outcomes. With a strong emphasis on research and development, Novai has gained recognition in the Medtech space, winning multiple awards and accolades, including Best MedTech Startup 2023 and First Place at Tech Nation Rising Stars Grand Final 2024. The company is well-positioned in the healthcare market, aiming to transform clinical trials and patient care in ophthalmology and beyond.
Founded: 2020
Core technology: DARC retinal biomarker + AI
Headcount (approx.): 20
Notable awards: Best MedTech Startup 2023; Tech Nation Rising Stars Grand Final 2024
Known investors: SFC Capital; Ascension Ventures
Early detection and monitoring of ophthalmic and neurodegenerative diseases; improving clinical-trial biomarkers and patient stratification.
2020
Biotechnology
£250,000
Dealroom entry listing a £250k seed investment (Dec 2024).
5328528
Public profile field reporting total funding amount in USD.
“SFC Capital; Ascension Ventures”